To help keep our community authentic, we're showing information about accounts on Linktree.
Kuros Biosciences has been a member of Linktree for 3 years and joined in December 2022. Resources kurosbio has populated their site with include: • Checking your browser - reCAPTCHA • Share Price - Kuros Biosciences • Growbone - Kuros Biosciences • Kuros Biosciences to showcase MagnetOs™ commercial momentum and plan for scalable quality growth at Capital Markets Day in Zürich - Kuros Biosciences • LinkedIn • edge.media-server.com • Project Fusion - Kuros Biosciences • Webinar Registration - Zoom • Kuros Biosciences reports 51% year-over-year increase in sales in the first three months of 2026 - Kuros Biosciences • MagnetOs™ Flex Matrix - Spinal Bone Graft - Kuros Biosciences • MagnetOs™ MIS - Kuros Biosciences • Careers - Kuros Biosciences • "Human histological evidence of bone formation using MagnetOs" presented by Dr. Robert Eastlack • Kuros Biosciences delivers 72% year-over-year sales growth, reaching USD 146.1 million for 2025 - Kuros Biosciences • A Retrospective Analysis of Early Outcomes from a Biphasic C... : Spine Open • Introducing MagnetOs MIS • Preclinical Evaluation of Synthetic Bone Graft Materials in an Instrumented Sheep Posterolateral Lumbar Spinal Fusion Model - PubMed • juniperpublishers.com • journals.lww.com • Corporate Corner - Kuros Biosciences • The impact of bone graft volume on risk of pseudarthrosis, screw loosening, and rod breakage in surgical correction of adult spinal deformity - PubMed • Kuros Biosciences to provide investor update at Octavian and Baader Bank Conferences - Kuros Biosciences • The Application of Biologic and Synthetic Bone Grafts in Scoliosis Surgery: A Scoping Review of Emerging Technologies - PubMed • Clinical Spine Surgery • Kuros Biosciences announces enrollment of first patient in ASTRA study – A global, prospective, randomized, multi-center clinical trial in foot and ankle fusion - Kuros Biosciences • Kuros Biosciences increases the annual guidance for 2025, The company reports 77% year-over-year increase for the first nine months of 2025 - Kuros Biosciences • Spinal Biologics Demystified—Separating Fact from Fiction - BroadWater, LLC | Medical Meetings—Society Management—Medical Marketing Services & Websites BroadWater, LLC | Medical Meetings—Society Management—Medical Marketing Services & Websites • Examination of clinical and radiographic outcomes after lumbar interbody fusion: a retrospective analysis of TLIF, MidLIF, and MIS-TLIF procedures - PubMed • Adverse Impact of Obesity on Lumbar Spine Fusion, Patient-reported Outcomes and Costs: A Systematic Review and Meta-analysis - PubMed • Comparative efficacy of autologous iliac bone versus allogeneic demineralized bone matrix in lateral lumbar interbody fusion using a novel minimally invasive iliac bone retrieval tool: a self-controlled study | Journal of Orthopaedic Surgery and Research • Meet the Expert - Kuros Biosciences • The effects of submicron‐textured surface topography on antibiotic efficacy against biofilms • Grow Bone with MagnetOs - Kuros Biosciences • Watch the H1 webcast here • Kuros Biosciences Reports First Half of 2025 Results - Kuros Biosciences • Baader Helvea Equity Research • Kuros Biosciences launches MagnetOs MIS Delivery System by completing first cases, and continues global expansion with incremental Brazil clearance - Kuros Biosciences • Limited evidence to support demineralized bone matrix in foot and ankle surgical procedures: A systematic review - PubMed • Fusion Rate of Biphasic Calcium Phosphate Bone Graft with Needle-Shaped Submicron Surface Topography in Interbody Lumbar Fusion for Degenerative Disc Disease: A Single-Center Retrospective Review • A Prospective Single-Center Histological Analysis of a Patient Tissue Biopsy from a MagnetOsTM Revision Case • A New Anatomical Nano Interbody Fusion Device for Elderly Patients Undergoing Anterior Discectomy and Interbody Fusion - Molecular Biotechnology • ClinicalTrials.gov • Meet the Team - Kuros Biosciences • Global Practices and Preferences in the Use of Osteobiologics for Anterior Cervical Discectomy and Fusion: A Cross-Sectional Study - PubMed • Welcome! You are invited to join a webinar: Spinal Biologics Demystified - Separating Fact from Fiction. After registering, you will receive a confirmation email about joining the webinar. • 𝖮𝗎𝗋 𝖼𝗈𝗆𝗉𝖾𝗍𝗂𝗍𝗂𝗈𝗇 𝗂𝗌𝗇’𝗍 𝗌𝗂𝗆𝗉𝗅𝗒 𝗈𝗍𝗁𝖾𝗋… | Kuros Biosciences | Extremities • Kuros Biosciences Seeks to Redefine Orthobiologics Market | ORTHOWORLD • kurosbio.com • Meet an Expert • 3D printing of different fibres towards HA/PCL scaffolding induces macrophage polarization and promotes osteogenic differentiation of BMSCs - PubMed • Kuros Biosciences grows sales to CHF 75.6 million for 2024 - Kuros Biosciences • Immunomodulation with M2 macrophage-derived extracellular vesicles for enhanced titanium implant osseointegration under diabetic conditions - PubMed • Bioceramic Surface Topography Regulating Immune Osteogenesis - PubMed • Development of MagnetOs NeedleGrip surface topography • MagnetOs Flex Matrix in the OR with Dr. Terrance Crowder • Effectiveness of synthetic versus autologous bone grafts in foot and ankle surgery: a systematic review and meta-analysis - PubMed • Job Openings at Kuros Biosciences • Kuros Biosciences USA, Inc. announces an exclusive strategic agreement with the Medtronic spinal division - Kuros Biosciences • Patient Comorbidities, Their Influence on Lumbar Spinal... : JAAOS - Journal of the American Academy of Orthopaedic Surgeons • Comparative Studies of Bone Graft and Orthobiologics for Foot Ankle Arthrodesis: A Critical Review - PMC • Kuros Biosciences Expands into Extremities Markets - Kuros Biosciences • Powered by Foot Innovate - Kuros Biosciences Corporate Webinar: Grow Bone with MagnetOs: History, Science & Data • Revolution Surgical | MedTech Distributor • Kuros reports 149% increase in direct MagnetOs sales and exceeds cash flow breakeven in the first nine months of 2024 - Kuros Biosciences • LEDA Orthopaedics Ltd., a United Kingdom medical device distributor • MagnetOs Formulations • Download to learn more about the Level 1 study featuring MagnetOs • Level 1 data, now published in Spine • Kuros Biosciences Reports First Half of 2024 Results - Kuros Biosciences • Biphasic Calcium Phosphate Bone Graft With a Unique Surface Topography: A Single-Center Ambispective Study for Degenerative Disease of the Lumbar Spine • MagnetOs in Clinical Practice • MagnetOs - Kuros Biosciences • Read the level 1 data publication on our website • Kuros Biosciences Job Openings • Read the full PR from June 25th on our website • Efficacy of Biphasic Calcium Phosphate Ceramic With a... : Spine • Early Radiographic and Clinical Outcomes of Three Patients Undergoing Open Instrumented Posterolateral Fusion Surgery with MagnetOsTM Easypack Putty • Meet the Expert • Kuros reports Corporate Highlights as of Q1 2024 including increase in direct MagnetOsTM sales • Predicting major complications and discharge disposition after adult spinal deformity surgery • The Effect of Smoking on Spinal Fusion • MagnetOs Clinical Evidence • Kuros reports 163% growth in direct MagnetOs sales and 153% increase in total medical device sales for the full year 2023 • Kuros Biosciences FY2023 Financial Report Investor Webcast • Kuros Biosciences FY-2023 Financial Report Investor Webcast • Kuros Biosciences to Report Full Year Financial Results for 2023 and Provide Corporate Update • MagnetOs™ Easypack Putty now cleared for Interbody use • Radiologic Evaluation of Interbody Fusion: A Review on Criteria Use and Accuracy • Cytokines: The Links Between Bone and the Immune System • Osteoimmunology in Spinal Fusion: Immune System Interactions • Kuros Biosciences to Present at the CG 2024 Musculoskeletal Conference • CG 2024 Musculoskeletal Conference • Media & Investors • Kuros Biosciences Secures FDA 510K and NZ Regulatory Clearances for MagnetOs Products • Job Opportunities • Website • Nanozyme-like Cerium Oxide for Osteoimmunology Modulation and Vascularized Osseointegration • Kuros Biosciences Announces Three Advancements Related to its MagnetOs Portfolio • Bone Homeostasis and Physiology in Normal and Orthopaedic Disease Conditions • Kuros Biosciences Announces Results from Two Prospective Randomized Clinical Trials • MagnetOs™ Flex Matrix in a TLIF with Dr. Crowder • Evaluating the Risk and Benefit of Cellular Bone Matrix in Spine Surgery: A Comprehensive Review • Initial Results of Open Instrumented Posterolateral Fusion Surgery Using MagnetOs™ Flex Matrix in Five Patients • MagnetOs™ Flex Matrix • Effects of PTH Analogues on Bone Density and Complications in Spinal Deformity Correction: 2-Year Radiological Study • Fibrin-PTH: First Drug-Biologic Combo for Spinal Fusion • Genetic factors shape bone formation in response to materials via the macrophage-osteoclast axis. • 3D-Printed PLAG/Black Phosphorus Scaffolds for Regulating Osteoimmune Microenvironment and Bone Regeneration • Kuros Biosciences Receives FDA Clearance for Use of MagnetOs in Interbody Spinal Cages • A review on inflammatory biomarkers in non-specific low back pain, both acute and chronic. • JP Morgan Annual LifeSci Partners Corporate Access Event • How do M2 macrophages influence bone healing? • Instrumented Versus Uninstrumented Posterolateral Fusion • M2 macrophage-derived exosomal miR-486-5p • Osteoinduction and osteoimmunology • What Do Surgeons Have To Say about MagnetOs? • MagnetOs • Education • Take Credit! eccElearning Lecture Series • Project Fusion • MagnetOs vs Autograft • Get In Touch • Press Release, 12 October 2023 • Decline in Separate Incision Autograft • Neurosurgery Podcast: From Operating Room, to Board Room • How can parathyroid hormone (PTH) influence bone healing? • September: JAAOS • Kuros Biosciences Announces Completion of Enrollment in the Fibrin-PTH Phase 2 Trial • Press Release: Results for First Half of 2023 • MagnetOs and Early Results in Clnical Practice • Press Release, 21 February 2023 • Investor Webcast Presentation Video • Varenicline reduces the elevated pseudarthrosis risk linked to nicotine • M2 macrophage-derived exosomes promote diabetic fracture healing • Local Application of Recombinant Peptide for Osteoporotic Bone Defect • Enhancing Osseointegration with Strontium Eucommia on Titanium Dental Implants • Early Experience - Endocrinology Preoperative • LLIF surgery to decrease the occurrence of adjacent-segment disease • Stepwise Replicable Approach to Negotiating Value • Single Cell RNA Sequencing • M2 Macrophages During Bone Fracture Repair • Surgical Level Selection in Adolescent Idiopathic... • Assessment Posterolateral Lumbar Fusion • Body Mass Index/Risk After Posterior Lumbar Spine Fusion • Becker's Spine Review • Calcium Phosphate with Submicron Topography • Surgical Treatment of Single-Level Lumbar Stenosis • Secondary Fracture Rate After Vertebral Osteoporotic-JBJS • Surgical Site Infection - Pseudarthrosis • Best New Spine Technologies 2022 Orthopedic This Week • Charcot Arthropathy of the Spine • Degenerative Spondylolisthesis